Galp Unveils EUR650 Million Investments in Biofuels, Hydrogen Facilities
By Mauro Orru
Galp said Monday that some 650 million euros ($692 million) would be invested in two large-scale projects in Portugal to reduce the carbon footprint of the Sines refinery and its products.
The Portuguese energy company said about EUR400 million would go toward an advanced biofuels unit that Galp is creating in a joint venture with Japan's Mitsui & Co., with the remaining amount allocated to a green hydrogen unit.
The joint venture, in which Galp holds a 75% stake, will invest in the advanced biofuels unit that will use waste residues to produce renewable diesel such as hydrotreated vegetable oil, and sustainable aviation fuel.
Separately, Galp will invest to develop a 100-megawatt electrolysis plant to produce renewable hydrogen.
"These investment decisions were made on the expectation that the fiscal and regulatory developments in Portugal will not hinder the success of such large-scale projects, ensuring that our industrial operations remain long-term competitive in a global playing field," said Galp Chair Paula Amorim.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
September 25, 2023 03:17 ET (07:17 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters